Letromina 2.5 mg Alpha Pharma

£36.00

Letromina 2.5 mg represents a pharmaceutical-grade aromatase inhibitor containing letrozole as its active compound. This research chemical is manufactured by Alpha Pharma for laboratory studies examining estrogen pathway modulation mechanisms.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Letromina 2.5 mg Alpha Pharma
Letromina 2.5 mg Alpha Pharma
£36.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Applications of Letromina 2.5 mg

Letromina 2.5 mg is a pharmaceutical-grade aromatase inhibitor containing letrozole, a potent non-steroidal compound developed for laboratory investigations into estrogen biosynthesis pathways. Researchers at Stroid UK Shop utilise this Alpha Pharma formulation to study the selective inhibition of the aromatase enzyme complex, which catalyses the conversion of androgens to estrogens in various tissue models. The compound’s high bioavailability and extended half-life make it particularly valuable for examining sustained estrogen suppression mechanisms in controlled laboratory environments.

Molecular Characteristics and Research Profile

Laboratory studies demonstrate letrozole’s exceptional binding affinity to the aromatase enzyme, with researchers investigating its mechanism of action through competitive inhibition studies. The compound exhibits remarkable selectivity for the CYP19A1 enzyme, allowing scientists to examine estrogen-dependent cellular processes without interfering with other steroidogenic pathways. Research applications extend to examining hormonal feedback loops, investigating estrogen receptor signalling cascades, and evaluating the compound’s effects on various biochemical markers. Studies often compare letrozole’s efficacy against other compounds found in estrogen blocker research categories, providing comprehensive data on aromatase inhibition mechanisms.

Technical Specifications

Letromina 2.5 mg Research Specifications
Parameter Value
Active Compound Letrozole
Concentration 2.5 mg per tablet
Manufacturer Alpha Pharma
Form Oral tablets
CAS Number 112809-51-5
Molecular Formula C17H11N5
Storage Room temperature, dry conditions
Purity Pharmaceutical grade

Research protocols often incorporate this compound alongside other investigative tools available through SARM research programmes and peptide studies, enabling comprehensive hormonal pathway research.

Regulatory Compliance Statement

Letromina 2.5 mg is supplied strictly for in-vitro research purposes and laboratory investigations only. This product is not intended for human consumption, therapeutic use, or any application outside controlled scientific research environments. All research must comply with applicable regulations and institutional guidelines.

Related